Analysis of the Influence of the Outbreak of COVID-19 on the Blood Supply of Whole Blood Preparation Components in 25 Central Blood Stations in China

doi:10.3969/j.issn.1671-2587.2024.02.014

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2024, Vol. 26 ›› Issue (2): 244-250.DOI: 10.3969/j.issn.1671-2587.2024.02.014

Previous Articles Next Articles

Analysis of the Influence of the Outbreak of COVID-19 on the Blood Supply of Whole Blood Preparation Components in 25 Central Blood Stations in China

GE Xiaoqin, FU Heng, HU Guanlin, et al

Qingdao Central Blood Station, Qingdao 266071

Received:2023-12-15 Online:2024-04-20 Published:2024-04-23

Abstract

Abstract: Objective To analyze whether the supply data of component blood from 25 central blood stations in China was affected by the COVID-19 during 2017 to 2022. Methods The distribution data of red blood cell components, frozen plasma, cryoprecipitate, pathogen inactivation frozen plasma, adjusted red blood cell components, and adjusted frozen plasma from 25 central blood stations in China during 2017—2022 was collected retrospectively. Based on the outbreak time of COVID-19, the distribution data of 2017—2019 was the non-COVID-19 group (referred to as the non-COVID-19 group), and that of 2020-2022 was the COVID-19 group (referred to as the COVID-19 group). Results The distribution amount of red blood cell components increased during 2017 to 2022, namely 2022>2021>2019>2020>2018>2017. There was a decrease of 19 724.12 U from 2019 to 2020, the showing a negative annual growth rate (-1.43%)in 2020, which was significantly correlated with central blood stations (P<0.05). The distribution amount of frozen plasma increased during 2017 to 2022, namely 2022>2021>2020>2019>2018>2017, which was significantly correlated with central blood stations (P<0.05) .The distribution of cryoprecipitate basically increased during 2017 to 2022, namely 2021>2022>2020>2019>2018>2017. There was a decrease of 6 303.72 U from 2021 to 2022, showing a negative annual growth rate (-1.54%) in 2020, which was significantly correlated with central blood stations (P<0.05). The distribution amount of pathogen inactivation frozen plasma increased during 2020 to 2022; the annual growth rate was negative in 2021 and positive in 2022.The distribution amount of adjusted red blood cell components decreased, and the annual growth rate was negative ; the distribution amount of adjusted frozen plasma decreased, and the annual growth rate was negative. Conclusion There were significant regional differences in the supply of whole-blood-prepared component blood from the 25 central blood stations in China, and there were different impact degrees by the COVID-19. In general, it had the most significant impact on the supply capacity in 2020. Blood re-distribution was one of the measures to ensure blood supply during the COVID-19 epidemic.

Key words: COVID-19, Blood supply, Red blood cell components, Frozen plasma, Cryoprecipitate, Pathogen inactivation frozen plasma

CLC Number:

R818.52⁺.1

GE Xiaoqin, FU Heng, HU Guanlin, et al. Analysis of the Influence of the Outbreak of COVID-19 on the Blood Supply of Whole Blood Preparation Components in 25 Central Blood Stations in China[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(2): 244-250.

References

[1] 邱艳,张新童,戚海,等.亚太血液联盟成员与大陆省级采供血机构部分执业指标比对结果比较分析[J].中国输血杂志,2020,33(11):1117-1122.
[2] 许岚,郭贺龙,朱丽莉,等.国内20家中心血站红细胞制品生产率的调查分析[J].临床输血与检验,2023,25(2):210-214.
[3] 彭成,胡官林,李丽,等.国内24家地市级血站全血制备成分血发放数据对比分析[J].中国输血杂志,2022,35(9):942-946.
[4] 张评,高国静,蔡峥,等.SARS流行期间北京市临床供血的管理[J].中华医院感染学杂志,2004,14(9): 1029-1030.
[5] 赵冬雁,马宏伟,汤丁洁,等.2018—2021年COVID-19疫情前后国内18家血液中心红细胞成分血供应情况分析[J].中国输血杂志,2023,36(10):892-898.
[6] 袁海清,净红利,朱丽莉,等.国内26家地市级血站红细胞成分血库存管理现状的探讨[J].临床输血与检验,2023,25(2):204-209.
[7] 田甜,邱艳,郭成城,等.采供血机构执业比对信息管理系统的开发建设[J].临床输血与检验,2017,19(1):13-17.
[8] 张宁,林永桔,杨艺,等.2016—2021年我国部分省级血液中心全血制备成分血供应能力分析[J].北京医学,2023,45(6):538-543.
[9] GRANDONE E,MASTROIANNO M,DI MAURO L,et al.Blood supply,transfusion demand and mortality in Italian patients hospitalised during nine months of COVID-19 pandemic[J].Blood Transfus,2022,20(4):292-298.
[10] MAGHSUDLU M,ESHGHI P,AMINI KAFI-ABAD S,et al.Blood supply sufficiency and safety management in Iran during the COVID-19 outbreak[J].Vox Sang,2021,116(2):175-180.
[11] BASAVARAJU S V,FREE R J,CHAVEZ ORTIZ J L,et al.Impact of the COVID-19 pandemic on blood donation and transfusions in the United States in 2020[J].Transfusion,2023,63(Suppl 4):S1-S7.
[12] 马杰,范亚欣,梁晓华.新冠肺炎疫情下采供血事业发展现状调研分析[J].中国输血杂志,2022,35(1):46-50.
[13] 常缨,赵凤绵,戚海,等.新冠疫情期间血液库存变化趋势及采供血形势分析[J].中国输血杂志,2021,34(7):747-750.
[14] 李殷芳,俞丽,王拥军,等.新冠肺炎疫情对浙江省采供血的影响及其应对[J].中国输血杂志,2020,33(8):791-793.
[15] 范亚欣,高勇,马杰,等.多措并举有效保障COVID-19疫情期间临床供血[J].中国输血杂志,2020,33(8):801-803.
[16] 任明,仇丰武,杨茹,等.跨地域采供血联动在新型冠状病毒肺炎疫情期间血液保障的实践与探讨[J].中国输血杂志,2020,33(8):794-796.
[17] 张斌,高明,周虎,等.新型冠状病毒肺炎输血患者的临床分析81例[J].中国输血杂志,2021,34(8):904-907.
[18] GEORGE T J,SHEASBY J,SHIH E,et al.Blood product utilization in patients with COVID-19 on ECMO[J].J Surg Res,2022,276:24-30.
[19] 康澜,李世林,杨春晖.血液成分中病原体灭活技术及其研究进展[J].临床输血与检验,2022,24(4):521-527.
[20] SAADAH N H,SCHIPPERUS M R,WIERSUM-OSSELTON J C,et al.Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands:comparing clinical use and transfusion reaction risks[J].Haematologica,2020,105(4):1158-1165.
[21] APBN.APBN rapid brief white paper:2019 novel coronavirus(SARS-CoV-2);Excepted challenges and risks to blood safty[R/OL].(2020-02-17)[2023-08-01].https://asia-pacificbloodnetwork.org/wp-content/uploads/2023/03/2019-No-vel-Coronavirus-White-Paper.pdf.
[22] World Health Orgnization.Maintaining a safe and adequate blood supply during the pandemic outbreak of coronavirus disease(COV-ID-19)[R/OL].(2021-02-17)[2023-08-01].https://www.who.int/publications/i/item/WHO-2019-nCoV-BloodSupply-2021-1.
[23] 易星,袁晓华,白林,等.我国38家采供血机构新冠肺炎康复者恢复期血浆采集制备供应实践经验[J].临床输血与检验,2022,24(3):285-291.
[24] 赵冬雁,王林,汤丁杰,等.我国省级采供血机构全血及红细胞成分血库存管理的回顾性研究[J].临床输血与检验,2023,25(1):119-127.
[25] 袁海清,净红利,朱丽莉,等.国内26家地市级血站红细胞成分血库存管理现状的探讨[J].临床输血与检验,2023,25(2):204-209.
[26] 郭逸,李恒新,郭康社,等.陕西省血液调配机制建立与运行[J].中国卫生质量管理,2021,28(12):80-82.
[27] 周华平,孔长虹,胡蔚兰,等.血液管理信息系统对血液调配流程的优化[J].中国输血杂志,2009,22(1):61-62.

Analysis of the Influence of the Outbreak of COVID-19 on the Blood Supply of Whole Blood Preparation Components in 25 Central Blood Stations in China

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	HUA Minyu, DING Yueping, WANG Zhenxing, et al. Influence of COVID-19 Epidemic on the Collection and Supply of Apheresis Platelets in Prefecture-Level Blood Stations in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 641-647.
[2]	Li Yiwen, YU-LAN Jingzi, TAO Yuqi, et al. Effect and Clinical Significance of FFP Infusion on Hemagglutination Index of Newborn [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(3): 383-387.
[3]	YI Xing, YUAN Xiao-hua, BAI Lin, et al. Practical Experience of COVID-19 Convalescent Plasma Collection,Preparation and Distribution by 38 Blood Stations in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(3): 285-290.
[4]	HU Qiu-yue, XU Shou-guang, ZHOU Yuan, et al. Organization and Management of Collection and Supply for COVID-19 Convalescent Plasma in Some Provinces and Cities in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(3): 291-296.
[5]	ZHANG Li-bo, HUANG Hui-qing, ZHAO Guo-qing, et al. Analysis of Recruitment and Demography of COVID-19 Convalescent Plasma Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(3): 297-301.
[6]	TANG Zong-sheng. Strategies to Enhance the Care and Privacy of Plasma Donors during COVID-19 Rehabilitation and Their Significance [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 458-461.
[7]	YU Feng-xiu, LI Jin-qi, ZHU Yan-xia, et al. Effect on the Quality of Cryoprecipitation from Fresh Frozen Plasma by High Speed Centrifugation Twice [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 477-480.
[8]	XIE Yu-bin, ZOU Bin-bin, CHEN Dong, et al.. Analysis of Health Status and Antibody Level of COVID-19 Convalescent Plasma Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(4): 343-348.
[9]	WANG Yun, ZHAO Chang-cheng, GU Yan, et al.. Analysis of Novel Coronavirus Pneumonia Related Blood Test Indexes in 80 Cases [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(4): 360-366.
[10]	YE Sheng, SHEN Yan, CHEN Jin, et al. Reengineering of Apheresis Donation Site and Workflow during COVID-19 Epidemic [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 241-245.
[11]	YING Shang-yun, ZHAO Yi-lun, YUAN Yong, et al. Strategies for the Prevention and Control of Emergency Group Blood Donation Sites during the COVID-19 Pandemic [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 253-258.
[12]	HUANG Qiong, XU Yun-yun, LIU Hai-yan, et al. Study on the Correlation between IgM Antibody and Bloodcell Count and C-reactive Protein in Patients with COVID-19 Convalescent Plasma [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 322-325.
[13]	PEI De-cui, ZHENG Jin-xiu. Retrospective Analysis of Appropriateness and Effectiveness of Fresh Frozen Plasmaused [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(1): 44-47.
[14]	LIN Jian-xia, ZHUO Xiao-fu, JIANG Wei-mei, et al. Influences of ABO Blood Group,Gender and Age on Factor VIII and Fibrinogen in the Plasma Component [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(6): 596-600.
[15]	LIANG Xiao-liu,LIN Zheng-min,JIANG Jian-feng,et al.. Alterations of Coagulation Markers in Preterm Infants with Fresh Frozen Plasma Transfusion [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(4): 374-376.